BlackRock, Inc. - Mar 31, 2025 SCHEDULE 13G Report for Lineage Cell Therapeutics Inc Common Stock (LCTX)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: Lineage Cell Therapeutics Inc Common Stock
Symbol: LCTX
Shares outstanding: 229M shares
Disclosed Ownership: 11.5M shares
Ownership: 5%
Form type: SCHEDULE 13G
Date filed: 4/24/2025, 08:48 AM
Date of event: Mar 31, 2025
Previous filing: Feb 5, 2025
Next filing: Jul 17, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	5%	11.5M	11.4M	0	Spencer Fleming	Managing Director